Avalon GloboCare (ALBT) had the highest return between March 1, 2017 and April 18, 2017 by a US stock, returning 10,001%.
| ASSET | DATE | % RETURN |
|---|---|---|
Avalon GloboCare (ALBT) | 3/1/2017 - 4/18/2017 | 10,001.01% |
Fubotv (FUBO) | 3/1/2017 - 4/18/2017 | 7,447.17% |
OLB (OLB) | 3/1/2017 - 4/18/2017 | 200% |
Synergy CHC Corp Common Stock (SNYR) | 3/1/2017 - 4/18/2017 | 173.74% |
TSS, Inc Common Stock (TSSI) | 3/1/2017 - 4/18/2017 | 156.01% |
Oncolytics Biotech (ONCY) | 3/1/2017 - 4/18/2017 | 153.68% |
InMed Pharmaceuticals (INM) | 3/1/2017 - 4/18/2017 | 136.5% |
Akari Therapeutics (AKTX) | 3/1/2017 - 4/18/2017 | 125.45% |
Plug Power (PLUG) | 3/1/2017 - 4/18/2017 | 106.42% |
LifeMD (LFMD) | 3/1/2017 - 4/18/2017 | 104.17% |
Clearpoint Neuro (CLPT) | 3/1/2017 - 4/18/2017 | 97.84% |
Nutex Health (NUTX) | 3/1/2017 - 4/18/2017 | 90.48% |
Aurinia Pharmaceuticals (AUPH) | 3/1/2017 - 4/18/2017 | 87.33% |
Pulse Biosciences (PLSE) | 3/1/2017 - 4/18/2017 | 87.27% |
Altisource Portfolio Solutions (ASPS) | 3/1/2017 - 4/18/2017 | 83.46% |
Everi (EVRI) | 3/1/2017 - 4/18/2017 | 75.77% |
TG Therapeutics (TGTX) | 3/1/2017 - 4/18/2017 | 75.44% |
Kaival Brands Innovations (KAVL) | 3/1/2017 - 4/18/2017 | 75% |
Lixte Biotechnology (LIXT) | 3/1/2017 - 4/18/2017 | 68.89% |
Immuron Ltd ADR (IMRN) | 3/1/2017 - 4/18/2017 | 68.72% |
Verastem (VSTM) | 3/1/2017 - 4/18/2017 | 68.7% |
Mesoblast (MESO) | 3/1/2017 - 4/18/2017 | 68.02% |
Harrow Health (HROW) | 3/1/2017 - 4/18/2017 | 63.64% |
Opus Genetics (IRD) | 3/1/2017 - 4/18/2017 | 61.98% |
Galectin Therapeutics (GALT) | 3/1/2017 - 4/18/2017 | 61.9% |
